| human | Q5 |
| P1960 | Google Scholar author ID | C0X0cR4AAAAJ |
| P6634 | LinkedIn personal profile ID | zuhierawan |
| P496 | ORCID iD | 0000-0002-4176-335X |
| P2038 | ResearchGate profile ID | Zuhier_Awan |
| P69 | educated at | Harvard Medical School | Q49121 |
| University of Illinois at Chicago | Q955764 | ||
| King Abdulaziz University | Q1795928 | ||
| P108 | employer | McGill University | Q201492 |
| King Abdulaziz University | Q1795928 | ||
| University of Jeddah | Q20411232 | ||
| King Abdul Aziz University Hospital | Q30254018 | ||
| P106 | occupation | researcher | Q1650915 |
| Q52959119 | A semi-automated mass spectrometric immunoassay coupled to selected reaction monitoring (MSIA-SRM) reveals novel relationships between circulating PCSK9 and metabolic phenotypes in patient cohorts. |
| Q88581580 | Assisting the integration of social media in problem-based learning sessions in the Faculty of Medicine at King Abdulaziz University |
| Q88546149 | Integrating an interprofessional education initiative: Evidence from King Abdulaziz University |
| Q98500972 | Optimized Nanostructured Lipid Carriers Integrated into In Situ Nasal Gel for Enhancing Brain Delivery of Flibanserin |
| Q52560430 | Posttranslational modification of proprotein convertase subtilisin/kexin type 9 is differentially regulated in response to distinct cardiometabolic treatments as revealed by targeted proteomics. |
| Q98511269 | Thymoquinone-Loaded Soy-Phospholipid-Based Phytosomes Exhibit Anticancer Potential against Human Lung Cancer Cells |
Search more.